Conexeu Sciences, Inc. (CNXU) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$2.40

From 52W high−86.82%

Volume201847.00

Market cap$62.62M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$2.40

From 52W high

−86.82%

Volume

201847.00

Market cap

$62.62M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

30.0

MomentumView details →

1D Return

−6.72%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−6.72%

YTD Return

—

1Y Return

—

RSI (14)

30.0

vs 50D SMA

−46.66%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.29

EPS Surprise

−190.00%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−190.00%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsJan 22, 2027 →

Latest newsMore news →

Conexeu Sciences Inc. offered inducement warrants to holders of existing warrants, exercisable for one common share at $3.00 per share for 24 months, in exchange for early exercise of existing warrants.8d ago

Conexeu Sciences Inc. announced a $5 million private placement led by existing shareholders, management and directors, with participation from its CEO and Chief Commercial Officer.20d ago

Similar companies

Spero Therapeutics, Inc.SPRO Cassava Sciences, Inc.SAVA Gossamer Bio, Inc.GOSS Cognition Therapeutics, Inc.CGTX Telomir Pharmaceuticals, Inc. Common StockTELO Fortress Biotech, Inc.FBIO Find similar companies →

Latest newsMore news →

Conexeu Sciences Inc. offered inducement warrants to holders of existing warrants, exercisable for one common share at $3.00 per share for 24 months, in exchange for early exercise of existing warrants.8d ago Conexeu Sciences Inc. announced a $5 million private placement led by existing shareholders, management and directors, with participation from its CEO and Chief Commercial Officer.20d ago Conexeu Sciences Inc. issued 416,667 shares of common stock and 416,667 incentive warrants upon exercise of outstanding warrants under its warrant exercise incentive program, raising approximately $166,667 in gross proceeds on June 4, 2026.149d ago